Henter, Ioline D.

Rapid Resolution of Suicidal Ideation After a Single Infusion of an N -Methyl- D -Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry

Treatment of Major DepressionSuicide and Self-Harm Studies

Cited by 564

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

Ibrahim, L., DiazGranados, N., Franco-Chaves, J., Brutsche, N., Henter, I. D., Kronstein, P., Moaddel, R., Wainer, I., Luckenbaugh, D. A., Manji, H. K., et al. (2012) · Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 309

The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments

Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 263

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 228

Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date

Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 220

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

Kadriu, B., Musazzi, L., Henter, I. D., Graves, M., Popoli, M., & Zarate, C. A. (2019) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 165

Ketamine Treatment for Depression: A Review

Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A. (2022) · Discover Mental Health

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 161

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · CNS Drugs

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 142

Defining anxious depression: a review of the literature

Ionescu, D. F., Niciu, M. J., Henter, I. D., & Zarate, C. A. (2013) · CNS Spectrums

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 119

Ketamine in neuropsychiatric disorders: an update

Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 108

The role of adipokines in the rapid antidepressant effects of ketamine

Machado-Vieira, R., Gold, P. W., Luckenbaugh, D. A., Ballard, E. D., Richards, E. M., Henter, I. D., De Sousa, R. T., Niciu, M. J., Yuan, P., & Zarate, C. A. (2017) · Molecular Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 102

Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants

Kadriu, B., Greenwald, M., Henter, I. D., Gilbert, J. R., Kraus, C., Park, L. T., & Zarate, C. A. (2021) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionPsychedelics and Drug Studies

Cited by 99

Translational research in bipolar disorder: emerging insights from genetically based models

Chen, G., Henter, I. D., & Manji, H. K. (2010) · Molecular Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 95

Novel glutamatergic agents for major depressive disorder and bipolar disorder

Machado-Vieira, R., Ibrahim, L., Henter, I. D., & Zarate, C. A. (2012) · Pharmacology Biochemistry and Behavior

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 92

The influence of ketamine on drug discovery in depression

Kraus, C., Wasserman, D., Henter, I. D., Acevedo-Diaz, E., Kadriu, B., & Zarate, C. A. (2019) · Drug Discovery Today

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 75

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., et al. (2020) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 63

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Duncan Jr, W. C., Slonena, E. E., Hejazi, N. S., Brutsche, N., Park, L. T., Henter, I. D., Ballard, E. D., & Zarate Jr, C. A. (2018) · Neuropsychiatric Disease and Treatment

Treatment of Major DepressionCircadian rhythm and melatonin

Cited by 17